CA2021501C - Compose pharmaceutique a usage topique - Google Patents

Compose pharmaceutique a usage topique Download PDF

Info

Publication number
CA2021501C
CA2021501C CA002021501A CA2021501A CA2021501C CA 2021501 C CA2021501 C CA 2021501C CA 002021501 A CA002021501 A CA 002021501A CA 2021501 A CA2021501 A CA 2021501A CA 2021501 C CA2021501 C CA 2021501C
Authority
CA
Canada
Prior art keywords
estradiol
composition
acetate
esters
vinyl pyrrolidone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002021501A
Other languages
English (en)
Other versions
CA2021501A1 (fr
Inventor
Izhak Blank
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2021501A1 publication Critical patent/CA2021501A1/fr
Application granted granted Critical
Publication of CA2021501C publication Critical patent/CA2021501C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
CA002021501A 1989-07-21 1990-07-19 Compose pharmaceutique a usage topique Expired - Fee Related CA2021501C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL91,067 1989-07-21
IL9106789A IL91067A (en) 1989-07-21 1989-07-21 Sustained-release transdermal pharmaceutical compositions comprising estrogens

Publications (2)

Publication Number Publication Date
CA2021501A1 CA2021501A1 (fr) 1991-01-22
CA2021501C true CA2021501C (fr) 2001-02-13

Family

ID=11060200

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002021501A Expired - Fee Related CA2021501C (fr) 1989-07-21 1990-07-19 Compose pharmaceutique a usage topique

Country Status (8)

Country Link
AU (1) AU5908790A (fr)
CA (1) CA2021501C (fr)
FI (1) FI903653A7 (fr)
IE (1) IE902573A1 (fr)
IL (1) IL91067A (fr)
NO (1) NO903257L (fr)
PT (1) PT94787B (fr)
ZA (1) ZA905671B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration

Also Published As

Publication number Publication date
PT94787A (pt) 1991-03-20
AU5908790A (en) 1991-01-24
IE902573A1 (en) 1991-02-27
IL91067A0 (en) 1990-02-09
NO903257L (no) 1991-01-22
IL91067A (en) 1995-08-31
ZA905671B (en) 1991-04-24
FI903653A0 (fi) 1990-07-19
PT94787B (pt) 1997-04-30
FI903653A7 (fi) 1991-01-22
NO903257D0 (no) 1990-07-20
CA2021501A1 (fr) 1991-01-22

Similar Documents

Publication Publication Date Title
EP0409383B1 (fr) Compositions à base d'estradiol et procédés d'application topique
US5232703A (en) Estradiol compositions and methods for topical application
JP3046346B2 (ja) 外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤
JP2573638B2 (ja) 経皮的生殖能調節システムおよび方法
US4482534A (en) Nitroglycerin preparations
US5102666A (en) Calcium polycarbophil controlled release composition and method
AU692504B2 (en) Percutaneously absorbable preparation
US5814329A (en) Hydrophilic polystyrene graft copolymer vehicle for intravaginal administration of pharmacologically active agents
US5242951A (en) Estrogen-containing gel preparation
WO1998020917A9 (fr) Vehicule copolymere greffe de polystyrene hydrophyle utilise pour l'administration intravaginale d'agents pharmaco-actifs
JP4841781B2 (ja) 改良された経皮的避妊薬送達系および方法
EP0613372B1 (fr) Implants sous-cutanes a base de derives de nomegestrol
Kaetsu et al. Controlled slow release of chemotherapeutic drugs for cancer from matrices prepared by radiation polymerization at low temperatures
JPS63264687A (ja) 塩基性の活性成分透過性の触圧接着性ポリマー材料及びその製造方法
US4857313A (en) Transdermal drug delivery device comprising copolymers of N-morpholinoethyl methacrylate and 2-hydroxylmethacrylate
CA2021501C (fr) Compose pharmaceutique a usage topique
CA2041330C (fr) Preparation d'eperisone ou de tolperisone a absorption percutanee
JPH11189546A (ja) 経皮吸収促進剤
CN1187042C (zh) 含甾族化合物的硬膏剂,其制备方法及其应用
JP3676567B2 (ja) 医療用粘着剤組成物及び医療用貼付剤
JPS5823367B2 (ja) 粘着テ−プ製剤
CN1313084C (zh) 一种透皮避孕药传送体系及制备方法
EP1047408A1 (fr) Composition medicamenteuse en comprime a liberation regulee renfermant une combinaison de polymeres
JPH02196714A (ja) 経皮吸収貼付剤
JPH02233617A (ja) 経皮吸収製剤

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed